1367P JNJ-70218902 (JNJ-902), a TMEFF2 x CD3 bispecific antibody, in prostate cancer: Initial results from a phase I dose escalation study

Autor: E. Calvo, B. Doger de Spéville, J. Carles Galceran, A. Peer, D.L. Sarid, B.J. Eigl, A. Avadhani, D. Yao, V. Lin, S. Wu, P. Jaiprasart, J. Loffredo, M. Tamegnon, H. Xie, A.R. Hansen

Publikováno v: Annals of Oncology. 33:S1166

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::64ed3940363c7a0c97d0761231ed416e
https://doi.org/10.1016/j.annonc.2022.07.1499

Sonographic evidence of abnormal tracheal cartilage ring structure in cystic fibrosis

Autor: Simon C. Kao, David A. Stoltz, Amit Diwakar, Kathryn Chaloner, Andrew S. Michalski, Rebecca A. Horan, Monelle M. Tamegnon, Ryan J. Adam, Anthony J. Fischer, David K. Meyerholz, Jan L. Launspach

Publikováno v: The Laryngoscope. 125:2398-2404

Objectives/Hypothesis Tracheal cartilage ring structural abnormalities have been reported in cystic fibrosis (CF) mice and pigs. Whether similar findings are present in humans with CF is unknown. We hypothesized that tracheal cartilage ring shape and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b79b8a1a152f9f16b6e547e7c1e49738
https://doi.org/10.1002/lary.25255

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial.

Autor: Burke GAA; Department of Paediatric Haematology, Oncology and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom., Vinti L; Department of Pediatric Hematology/Oncology and Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, Rome, Italy., Kabickova E; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic., Beishuizen A; Department of Hemato-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Hematology/Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands., Tacyildiz N; Department of Pediatric Hematology and Oncology, Ankara University Cebeci Hospital, Ankara, Turkey., Uyttebroeck A; Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Kang HJ; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Wide River Institute of Immunology, Seoul National University Children's Hospital, Seoul, South Korea., Luisi F; Pediatric Oncology Institute, GRAACC, São Paulo, Brazil., Minard-Colin V; Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Burkhardt B; Pediatric Hematology and Oncology, University Hospital Münster, Münster, Germany., Tamegnon M; Clinical Oncology, Janssen Research & Development, Raritan, NJ., Sun S; Clinical Biostats, Janssen Research & Development, Raritan, NJ., Curtis M; Clinical Oncology, Janssen Research & Development, High Wycombe, United Kingdom., Deshpande S; Clinical Oncology, Janssen Research & Development, Raritan, NJ., Nottage K; Clinical Oncology, Janssen Research & Development, Raritan, NJ., Howes A; Clinical Oncology, Janssen Research & Development, High Wycombe, United Kingdom., Srinivasan S; Oncology Translational Research, Janssen Research & Development, Lower Gwynedd Township, PA., Bhojwani D; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA., Norris R; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH., Cairo M; Departments of Pediatrics, Medicine, Pathology, Microbiology & Immunology, and Cell Biology, New York Medical College, Valhalla, NY.

Publikováno v: Blood advances [Blood Adv] 2023 Feb 28; Vol. 7 (4), pp. 602-610.